Nanoparticles that help protect lungs from chlorine damage
Cationic CAMKIIN nanoparticles that reduce chlorine-induced airway oxidative stress
This study is looking at a special treatment using tiny particles to see if it can help protect the lungs of mice from damage caused by chlorine exposure, with the hope of finding better ways to keep our lungs healthy when faced with harmful chemicals.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10698067 on NIH RePORTER |
What this research studies
This research investigates how a specific nanoparticle treatment can reduce lung damage caused by chlorine exposure. The approach involves using a CaMKII inhibitor peptide encapsulated in nanoparticles, which are delivered directly to the lungs of mice. By studying the effects of this treatment on inflammation and oxidative stress in the airways, the researchers aim to understand how to better protect lung health from harmful chemicals. The study focuses on the cellular mechanisms involved in lung injury and recovery.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals with respiratory issues or those exposed to chlorine in occupational or environmental settings.
Not a fit: Patients who do not have respiratory conditions or who have not been exposed to chlorine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that protect patients' lungs from damage caused by chlorine and similar harmful agents.
How similar studies have performed: While the specific approach using CaMKII inhibitors in nanoparticles is novel, similar strategies targeting oxidative stress in lung conditions have shown promise in other studies.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Salem, Aliasger K — University of Iowa
- Study coordinator: Salem, Aliasger K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.